2020 Breast Cancer Coordinated Care (BC3) Conference is organized by MedStar Georgetown University Hospital and will be held from Feb 27 - 29, 2020 at Grand Hyatt Washington, Washington, Dist Of Col, United States of America.
This program is specifically designed to be a multidisciplinary program and is intended for a wide range of medical practitioners who are interested in the latest information regarding the local treatment of breast cancer. The program is purposely targeted for general, plastic, breast and oncologic surgeons, as well as radiation and medical oncologists. It is also intended for primary care physicians, oncology nurses and practitioners, physical therapists, occupational therapists, genetic counselors, hospital administrators and other members of the healthcare team who have an interest in the treatment of breast cancer patients.
This activity was planned by and for the healthcare team, and learners will receive 15 Interprofessional Continuing Education (IPCE) credits for learning and change.
The meeting will offer presentations and panel discussions on a number of currently important topics in the local treatment of breast cancer including oncoplastic surgery and the role of prophylactic mastectomy. Experts in the field will cover the state of partial breast irradiation, intraoperative radiation therapy, timing and indications for post-mastectomy radiation, and neoadjuvant chemotherapy and its role in restaging breast cancer. Additionally, the program will examine nipple-sparing mastectomy, both therapeutic and prophylactic, treatment of breast cancer in a previously augmented breast, the status of MRI screening for breast cancer, the effects of reconstruction on the delivery of post-mastectomy radiation, and the evolving role of alloplastic materials in breast reconstruction. It will also cover in depth the state-of-the-art emerging field of lymphatic surgery to treat lymphedema. The latest updates on national trends and data on financial toxicity related to cancer care will also be discussed.
This three-day symposium will evaluate and discuss different models for coordination of breast cancer care from major centers across the United States. The meeting’s intent is not only to educate the faculty and attendees about the wide range of options available for breast cancer coordinated care but also to encourage the development of more standardized treatment strategies and protocols for the local treatment of breast cancer. Participating in the three-day symposium will give you access to:
• Three-day education agenda with live lectures, presentations, panel discussions and interactive Q&A sessions
• Poster abstracts authors’ session
• Multiple symposia
• Identify dueling perspectives and controversies in coordinated local treatment of breast cancer and reconstruction
• Describe tips and tricks: Learn surgical techniques to obtain vascularized mastectomy planes
• Define Nipple Sparing Mastectomy and Ptosis review selection criteria, timing, and staging
• Explain contralateral prophylactic mastectomy looking at current position, indications, and how to counsel patients
• Interpret the need to go opioid free with understanding of implementing narcotic sparing pathways, such as enhanced recovery after surgery (ERAS) protocol
• Analyze changing the Paradigm and Same day discharge after mastectomy and reconstruction
• Examine what are the barriers to care and understand current issues with healthcare delivery of surgical care and breast reconstruction
• Critique emerging technologies in radiation and how does proton beam and IORT fit into my practice?
• Discuss timing of radiation and reconstruction and review different philosophies regarding radiation delivery and how to minimize side effects
• Classify current accepted indications for radiation in breast cancer care
• Evaluate whether all patients should get genetic testing: Understand the current evidence for genetic testing in breast cancer care
• Measure whether to downstage with Neoadjuvant and how to use chemotherapy to manage advanced tumors prior to surgery
• Recognize how to navigate care in a world of BIA-ALCL and learn the current believed pathogenesis, epidemiology, and its impact on prosthetic reconstruction
• Identify what is right for my patient? and recognize the different methods of breast reconstruction including prosthetic-based, autologous, and microsurgical-assisted free flap reconstruction
• Summarize non-microsurgical reconstruction without implants and determine how fully autologous reconstruction can be achieved without microsurgery, using the latissimus dorsi and immediate fat transplantation (LIFT) flap
• Translate cutting edge in Lymphedema care and compare new options available and how microsurgery can both prevent and treat lymphedema
|Contact No. :||202-780-1655
January 10, 2020
|Registration Type||Last Date||Price|
|Physician - Early Fee||31 Dec,2019||USD 799.00|
|Advanced Practice Clinician - Early Fee||31 Dec,2019||USD 549.00|
|Resident/Fellow - Early Fee||31 Dec,2019||USD 199.00|
|Nurse - Early Fee||31 Dec,2019||USD 549.00|
|Physical Therapist - Early Fee||31 Dec,2019||USD 549.00|
|Occupational Therapist - Early Fee||31 Dec,2019||USD 549.00|
|Allied Health Professional - Early Fee||31 Dec,2019||USD 549.00|
|Industry Representative - Early Fee||31 Dec,2019||USD 949.00|
|One Day Rate Physician - Early Fee||31 Dec,2019||USD 399.00|
|One Day Rate PT/OT/APH - Early Fee||31 Dec,2019||USD 349.00|